Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

428 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia.
Cuesta-Mateos C, Fuentes P, Schrader A, Juárez-Sánchez R, Loscertales J, Mateu-Albero T, Vega-Piris L, Espartero-Santos M, Marcos-Jimenez A, Sánchez-López BA, Pérez-García Y, Jungherz D, Oberbeck S, Wahnschaffe L, Kreutzman A, Andersson EI, Mustjoki S, Faber E, Urzainqui A, Fresno M, Stamatakis K, Alfranca A, Terrón F, Herling M, Toribio ML, Muñoz-Calleja C. Cuesta-Mateos C, et al. Among authors: fresno m. Biomark Res. 2020 Oct 24;8:54. doi: 10.1186/s40364-020-00234-z. eCollection 2020. Biomark Res. 2020. PMID: 33110606 Free PMC article.
Cyclooxygenase 2 Effector Genes as Potential Inflammation-Related Biomarkers for Colorectal Cancer Circulating Tumor Cells Detection by Liquid Biopsy.
Stamatakis K, Torres-Gérica P, Jiménez-Segovia A, Ramos-Muñoz E, Crespo-Toro L, Fuentes P, Toribio ML, Callejas-Hernández F, Carrato A, García Bermejo ML, Fresno M. Stamatakis K, et al. Among authors: fresno m. Front Pharmacol. 2022 Jan 28;12:806395. doi: 10.3389/fphar.2021.806395. eCollection 2021. Front Pharmacol. 2022. PMID: 35153760 Free PMC article.
Cyclooxygenase-2: a therapeutic target in angiogenesis.
Iñiguez MA, Rodríguez A, Volpert OV, Fresno M, Redondo JM. Iñiguez MA, et al. Among authors: fresno m. Trends Mol Med. 2003 Feb;9(2):73-8. doi: 10.1016/s1471-4914(02)00011-4. Trends Mol Med. 2003. PMID: 12615041 Review.
Cyclooxygenase-independent inhibitory effects on T cell activation of novel 4,5-dihydro-3 trifluoromethyl pyrazole cyclooxygenase-2 inhibitors.
Iñiguez MA, Punzón C, Cacheiro-Llaguno C, Díaz-Muñoz MD, Duque J, Cuberes R, Alvarez I, Andrés EM, Buxens J, Buschmann H, Vela JM, Fresno M. Iñiguez MA, et al. Among authors: fresno m. Int Immunopharmacol. 2010 Oct;10(10):1295-304. doi: 10.1016/j.intimp.2010.07.013. Epub 2010 Aug 10. Int Immunopharmacol. 2010. PMID: 20709632
A role for stroma-derived annexin A1 as mediator in the control of genetic susceptibility to T-cell lymphoblastic malignancies through prostaglandin E2 secretion.
Santos J, González-Sánchez L, Matabuena-Deyzaguirre M, Villa-Morales M, Cozar P, López-Nieva P, Fernández-Navarro P, Fresno M, Díaz-Muñoz MD, Guenet JL, Montagutelli X, Fernández-Piqueras J. Santos J, et al. Among authors: fresno m. Cancer Res. 2009 Mar 15;69(6):2577-87. doi: 10.1158/0008-5472.CAN-08-1821. Epub 2009 Feb 24. Cancer Res. 2009. PMID: 19244132 Free article.
428 results